Protein Summary
DNA repair enzyme that incises DNA at 8-oxoG residues. Excises 7,8-dihydro-8-oxoguanine and 2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine (FAPY) from damaged DNA. Has a beta-lyase activity that nicks DNA 3' to the lesion. This gene encodes the enzyme responsible for the excision of 8-oxoguanine, a mutagenic base byproduct which occurs as a result of exposure to reactive oxygen. The action of this enzyme includes lyase activity for chain cleavage. Alternative splicing of the C-terminal region of this gene classifies splice variants into two major groups, type 1 and type 2, depending on the last exon of the sequence. Type 1 alternative splice variants end with exon 7 and type 2 end with exon 8. All variants share the N-terminal region in common, which contains a mitochondrial targeting signal that is essential for mitochondrial localization. Many alternative splice variants for this gene have been described, but the full-length nature for every variant has not been determined. [pro ...more
- ENST00000302003
- ENSP00000305584
- ENSG00000114026
- ENST00000302008
- ENSP00000305527
- ENST00000302036
- ENSP00000306561
- ENST00000339511
- ENSP00000345520
- ENST00000344629
- ENSP00000342851
- ENST00000349503
- ENSP00000303132
- ENST00000383826
- ENSP00000373337
- ENST00000449570
- ENSP00000403598
- MMH
- MUTM
- OGH1
- HMMH
- MUTM
- OGH1
- HOGG1
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
disease | 0.95 | ||
biological process | 0.91 | ||
molecular function | 0.91 | ||
disease perturbation | 0.87 | ||
histone modification site profile | 0.83 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 1581.97 (req: < 5)
Gene RIFs: 491 (req: <= 3)
Antibodies: 428 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 1581.97 (req: >= 5)
Gene RIFs: 491 (req: > 3)
Antibodies: 428 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 25
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 7
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0